Immunexpress, U of Amsterdam Academic Medical Center Form Sepsis Biomarker Alliance | GenomeWeb

NEW YORK (GenomeWeb) – Immunexpress announced yesterday that it has formed a four-year alliance with the University of Amsterdam's Academic Medical Center (AMC) to characterize and clinically evaluate sepsis-related biomarker signatures of host response.

The partners will specifically evaluate proprietary biomarker signatures, as well as novel RNA, protein, and epigenetic biomarkers, with the goal of advancing Immunexpress' pipeline of host response products for the management of patients with or suspected of having sepsis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.